• Overview
    • Why Invest
    • Press Releases & News
    • Events & Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • SEC Filings
      • Historical Financial Tables
    • Governance
      • Executive Leadership Team
      • Board of Directors
      • Committee Composition
      • Governance Documents
      • Contact the Board
    • Resources
      • Supplemental Information
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
Skip to main content
Evolus, Inc Evolus, Inc

Executive Leadership Team

  • Overview
    • Why Invest
    • Press Releases & News
    • Events & Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • SEC Filings
      • Historical Financial Tables
    • Governance
      • Executive Leadership Team
      • Board of Directors
      • Committee Composition
      • Governance Documents
      • Contact the Board
    • Resources
      • Supplemental Information
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts

Executive Management

Portrait

David Moatazedi, President and Chief Executive Officer

David Moatazedi has served as our President, Chief Executive Officer and as a member of our board of directors, since May 2018. Prior to that time, Mr. Moatazedi was the Senior Vice President at Allergan, Inc., or Allergan, and division head of the U.S. Medical Aesthetics division, which includes facial aesthetics, plastic surgery, regenerative medicine, body contouring, and skin care products from March 2016 to May 2018. From March 2017 to June 2020, Mr. Moatazedi served as a member of the board of directors of Obalon Therapeutics, Inc., a public medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Mr. Moatazedi worked in various leadership capacities within Allergan since March 2005, including as Vice President, Sales and Marketing of the U.S. Facial Aesthetics division from August 2014 to March 2016 and Vice President, Sales and Marketing of the U.S. Plastic Surgery division from February 2013 to August 2014. Prior to Allergan, Mr. Moatazedi was a district manager at Novartis Pharmaceuticals for the Dermatology division. Mr. Moatazedi holds an M.B.A. from Pepperdine University and a B.A. from California State University, Long Beach.

Portrait

Sandra Beaver, Chief Financial Officer

Sandra Beaver has served as our Chief Financial Officer since September 2022. From October 2019 to September 2022, Mrs. Beaver served as Senior Vice President of Finance at Experian, a global information services company, where she was responsible for half of company’s North America B2B business units. From November 2002 to September 2019, Mrs. Beaver held roles with increasing levels of responsibility and scope including Vice President of Consolidated Financial Planning & Analysis, and Vice President and Chief Financial Officer at Game Technology PLC. Mrs. Beaver holds a B.A. from the Isenberg School of Management at the University of Massachusetts Amherst.

Portrait

Rui Avelar, Chief Medical Officer and Head of Research and Development

Rui Avelar, M.D. has served as our Chief Medical Officer since January 2014 and was appointed to the additional position of Head of Research and Development in August 2018. From January 2014 to February 2018, Dr. Avelar also served as the Chief Medical Officer of Alphaeon. From March 2011 to December 2013, he served as Chief Medical Officer of Allergan Medical, where he was responsible for clinical development, clinical operations, safety, medical writing, biostatistics and regulatory matters. Dr. Avelar holds a M.D. from the University of Toronto and has received training accreditation in Sports Medicine from the Canadian Academy of Sports Medicine.

Portrait

Jeff Plumer, General Counsel

Jeff Plumer joined Evolus in 2014 as VP, Legal and Corporate Secretary and was promoted to General Counsel in November 2020. Previously, he was a corporate attorney at K&L Gates, a fully integrated law firm located across five continents, where he worked on a wide range of legal matters including mergers and acquisitions, capital markets transactions, corporate governance issues and intellectual property transactions. Jeff received his J.D. from the University of California, Davis School of Law and his B.A. from the University of Colorado at Boulder.

Follow on LinkedIn

Portrait

Jessica Novak, Senior Vice President, Human Resources

Jessica Novak joined Evolus in November 2021 as Senior Vice President, Human Resources. Prior to Evolus, Jessica was Senior Vice President in charge of total rewards, organizational and talent development, and learning and culture functions at RGP, a next-generation global human capital firm. Prior to RGP, Jessica was the global head of HR and a member of the Executive Leader Team at Ambry Genetics and has additional experience in the manufacturing, pharmaceuticals, and education industries. A board member of the National Human Resource Association, Jessica earned a B.S. in Psychology and Sociology with a minor in Business Administration at the University of Oregon. She also earned her M.S. in Human Resources Management at Chapman University.

Follow on LinkedIn

Portrait

Kurt Knab, Senior Vice President, Sales

Kurt Knab joined Evolus in August 2018 as Vice President of Sales. Prior to Evolus, Kurt served as VP of Sales at Medline Industries, a privately held manufacturer and distributor of medical supplies. Before Medline, Kurt held multiple sales leadership roles at Lifecell Corporation culminating in VP of Sales. Kurt has more than two decades of experience in the medical and aesthetic industries. He earned his B.S. in Marketing from Pennsylvania State University.

Follow on LinkedIn

Contact Us

David K. Erickson
Vice President, Investor Relations

949.966.1798
david.erickson@evolus.com
IR@evolus.com

Quick Links

  • SEC Filings
  • Investor FAQs
  • Information Request Form

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Evolus, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Evolus to send you the requested Investor Email Alert updates.

* Required

*
Investor Alert Options
*



Unsubscribe

Email Alert Sign Up Confirmation

REQUEST A MEETING WITH MANAGEMENT >
Evolus, Inc
  • Privacy Policy
  • Terms of Use
© Evolus, Inc. - All rights reserved
Powered By Q4 Inc. 5.90.0.6 (opens in new window)